| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Organized hematoma in the paranasal sinus and nasal cavity--imaging diagnosis and pathological findings.
|
Auris Nasus Larynx
|
2009
|
1.02
|
|
2
|
Synovial sarcoma of the head and neck: rare case of cervical metastasis.
|
Head Neck
|
2009
|
0.98
|
|
3
|
Vascular malformations of the head and neck.
|
Auris Nasus Larynx
|
2012
|
0.97
|
|
4
|
A new aspect of tri-modal therapy with superselective intra-arterial chemotherapy in maxillary sinus carcinoma.
|
Acta Otolaryngol Suppl
|
2007
|
0.96
|
|
5
|
In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP(4) receptor antagonist.
|
Life Sci
|
2007
|
0.93
|
|
6
|
Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation.
|
Eur J Pharmacol
|
2007
|
0.91
|
|
7
|
Efficient synthesis of [6-chloro-2-(4-chlorobenzoyl)-1H-indol-3-yl]-acetic acid, a novel COX-2 inhibitor.
|
J Org Chem
|
2003
|
0.89
|
|
8
|
Primary intraosseous squamous cell carcinoma of the jaw: two new cases and review of the literature.
|
Eur Arch Otorhinolaryngol
|
2012
|
0.87
|
|
9
|
The aggravating factors of hyperammonemia related to 5-fluorouracil infusion--a report of two cases.
|
Auris Nasus Larynx
|
2007
|
0.87
|
|
10
|
Recurrent cancer of the parotid gland: how well does salvage surgery work for locoregional failure?
|
ORL J Otorhinolaryngol Relat Spec
|
2009
|
0.85
|
|
11
|
Tumor-induced osteomalacia originating from the temporal bone: a case report.
|
Head Neck
|
2010
|
0.85
|
|
12
|
Novel imidazole compounds as a new series of potent, orally active inhibitors of 5-lipoxygenase.
|
Bioorg Med Chem
|
2003
|
0.82
|
|
13
|
Malignant melanoma of nasal cavity: report of 16 Japanese patients.
|
Auris Nasus Larynx
|
2004
|
0.80
|
|
14
|
Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese.
|
Auris Nasus Larynx
|
2008
|
0.80
|
|
15
|
Reversible impairment of auditory callosal pathway in 5-fluorouracil-induced leukoencephalopathy: parallel changes in function and imaging.
|
Otol Neurotol
|
2006
|
0.80
|
|
16
|
Long-term outcome following radical temporal bone resection for lateral skull base malignancies: a neurosurgical perspective.
|
J Neurosurg
|
2008
|
0.80
|
|
17
|
Carcinoid tumor of the larynx: clinical analysis of 33 cases in Japan.
|
Acta Otolaryngol Suppl
|
2007
|
0.79
|
|
18
|
Partial laryngectomy to treat early glottic cancer after failure of radiation therapy.
|
Arch Otolaryngol Head Neck Surg
|
2002
|
0.79
|
|
19
|
Optimization of imidazole 5-lipoxygenase inhibitors and selection and synthesis of a development candidate.
|
Chem Pharm Bull (Tokyo)
|
2005
|
0.78
|
|
20
|
RET/PTC fusion gene rearrangements in Japanese thyroid carcinomas.
|
Eur Arch Otorhinolaryngol
|
2004
|
0.78
|
|
21
|
Prognostic factors for hypopharyngeal cancer: a univariate and multivariate study of 142 cases.
|
Acta Otolaryngol Suppl
|
2007
|
0.77
|
|
22
|
Diagnosis of nasopharyngeal carcinoma metastatic to mediastinal lymph nodes by endoscopic ultrasonography-guided fine-needle aspiration biopsy.
|
Acta Otolaryngol
|
2005
|
0.76
|
|
23
|
Pharmacological separation between peripheral and central functions of cyclooxygenase-2 with CIAA, a novel cyclooxygenase-2 inhibitor.
|
Eur J Pharmacol
|
2006
|
0.76
|
|
24
|
[Clinical study of parapharyngeal space tumors].
|
Nihon Jibiinkoka Gakkai Kaiho
|
2004
|
0.75
|
|
25
|
Planned simultaneous cervical skin reconstruction for salvage total pharyngolaryngectomy.
|
Jpn J Clin Oncol
|
2008
|
0.75
|
|
26
|
[Clinical inspection of metastasis to the mesenteric lymph nodes in patients with hypopharyngeal cancer after pharyngolaryngectomy with free jejunal graft-136 cases].
|
Nihon Jibiinkoka Gakkai Kaiho
|
2006
|
0.75
|
|
27
|
Highly malignant submandibular extraskeletal osteosarcoma in a young patient.
|
Auris Nasus Larynx
|
2008
|
0.75
|
|
28
|
Characterization of binding affinity of CJ-023,423 for human prostanoid EP4 receptor.
|
Pharmacology
|
2008
|
0.75
|
|
29
|
A clinical study of post-cricoid carcinoma.
|
Acta Otolaryngol Suppl
|
2007
|
0.75
|